Drawing for MAXYGENE

USPTO serial 76098615

MAXYGENE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
HICKEY,TONI
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAXYGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie K. Wade

STEPHANIE K WADE ARENT FOX KINTNER PLOTKIN & KAHN, PLLC1050 CONNECTICUT AVE NWWASHINGTON, DC 20036-5339UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001biochemicals, namely, polynucleic acids and polypeptides for scientific, research and commercial use; biochemicals for in vitro and in vivo scientific, research and commercial use; plant growth regulators; polypeptides, genes and polynucleic acids for agricultural use; and genes and enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, pharmaceuticals, diagnostics, medicine, bioremediation, decontamination, detoxification, and cleaningACTIVE
005pharmaceutical preparations for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, respiratory tract, and renal and urinary tract diseases and disorders; pharmaceutical preparations, namely, analgesics, antibiotics, anti-cancer preparations, anti-infectives, anti-parsitics, antivirals; insulin; hormones; medical diagnostic preparations and reagents; herbicides, pesticides, biopesticides, miticides, and weed killers, all for agricultural and domestic use; vaccines; adjuvents for use with vaccinesACTIVE
031living plants, namely transgenic plantsACTIVE
040directed evolution services, namely the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, chemistry, agriculture, medicine, and industryACTIVE
042chemical research services; scientific research services; research and testing services in the fields of bacteriology and virology; research and product development services for others in the fields of genetics and gene therapy, transgenic plants, chemistry, pharmaceuticals, medical diagnostics, pesticides, biopesticides, cytotoxic agents, bacteriology, virology, biocatalysis, metabolic pathways and biochemical pathwaysACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 13, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 14, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2002NPUBNOTICE OF PUBLICATION
Sep 25, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance